These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19837691)

  • 1. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.
    Gendzekhadze K; Norman PJ; Abi-Rached L; Graef T; Moesta AK; Layrisse Z; Parham P
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18692-7. PubMed ID: 19837691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.
    Hirayasu K; Ohashi J; Kashiwase K; Hananantachai H; Naka I; Ogawa A; Takanashi M; Satake M; Nakajima K; Parham P; Arase H; Tokunaga K; Patarapotikul J; Yabe T
    PLoS Pathog; 2012; 8(3):e1002565. PubMed ID: 22412373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
    Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
    PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
    Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
    J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
    Hölzemer A; Thobakgale CF; Jimenez Cruz CA; Garcia-Beltran WF; Carlson JM; van Teijlingen NH; Mann JK; Jaggernath M; Kang SG; Körner C; Chung AW; Schafer JL; Evans DT; Alter G; Walker BD; Goulder PJ; Carrington M; Hartmann P; Pertel T; Zhou R; Ndung'u T; Altfeld M
    PLoS Med; 2015 Nov; 12(11):e1001900; discussion e1001900. PubMed ID: 26575988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
    Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
    Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarkably Low KIR and HLA Diversity in Amerindians Reveals Signatures of Strong Purifying Selection Shaping the Centromeric KIR Region.
    Vargas LB; Beltrame MH; Ho B; Marin WM; Dandekar R; Montero-Martín G; Fernández-Viña MA; Hurtado AM; Hill KR; Tsuneto LT; Hutz MH; Salzano FM; Petzl-Erler ML; Hollenbach JA; Augusto DG
    Mol Biol Evol; 2022 Jan; 39(1):. PubMed ID: 34633459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
    Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
    J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa.
    Mori M; Leitman E; Walker B; Ndung'u T; Carrington M; Goulder P
    J Infect Dis; 2019 Apr; 219(9):1456-1463. PubMed ID: 30520960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [KIR-HLA class i and pulmonary tuberculosis in the Amerindian population in Chaco, Argentina].
    Habegger de Sorrentino A; Pardo R; Marinic K; Duarte SC; Lotero C
    Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):565-9. PubMed ID: 24332713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2
    Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ
    J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
    Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
    J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
    Roberts CH; Molina S; Makalo P; Joof H; Harding-Esch EM; Burr SE; Mabey DC; Bailey RL; Burton MJ; Holland MJ
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2744. PubMed ID: 24651768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
    Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
    J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.